UTAH MEDICAL PRODUCTS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-03-27
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $77.00K, a 148.39% increase from fiscal 2023.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $31.00K, a 78.01% decline from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $141.00K, a 76.14% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-27 |
| 2024-12-31 | $77.00K 10-K · filed 2026-03-27 |
| 2023-12-31 | $31.00K 10-K · filed 2026-03-27 |
| 2022-12-31 | $141.00K 10-K · filed 2025-03-26 |
| 2021-12-31 | $591.00K 10-K · filed 2024-03-26 |
| 2020-12-31 | $371.00K 10-K/A · filed 2023-03-28 |
| 2019-12-31 | $354.00K 10-K · filed 2022-03-25 |
| 2018-12-31 | $812.00K 10-K · filed 2021-03-26 |
| 2017-12-31 | $270.00K 10-K · filed 2020-03-16 |
| 2016-12-31 | $372.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |